Health ❯ Healthcare ❯ Clinical Trials

Drug Trials

Phase 3 Trials Eli Lilly Trials Daraxonrasib Weight Loss Drugs PATHFNDR Trials Fenebrutinib Ambroxol Phase 1b Trials Pembrolizumab Cancer Research Double-Blind Trials Elraglusib GLP-1 Drugs Bile Duct Cancer Trials Phase Two Trials OTOF Gene Therapy Mounjaro Trials VIKTORIA-1 Trial MND Treatment Lecanemab Targeted Therapy BHF Funded Trials Motor Neurone Disease Treatments Niraparib Study Efficacy Studies Epcoritamab

Eli Lilly Opens Limited Early Access to Experimental Obesity Drug Retatrutide

The company says it will review physician requests under narrow medical criteria to supply a small number of patients with the drug before a planned FDA filing.

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

KOMET-007 Shows 600 mg Ziftomenib Plus Venetoclax/Azacitidine Achieves Deep Remissions in NPM1‑Mutated AML

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug